Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kawanabe, Yoshifumi ^a,c   Takahashi, Maki ^a   Jin, Xingjian ^a   Abdul Majeed, Shakila ^a   Nauli, Andromeda M ^b   Sari, Youssef ^a   Nauli, Surya M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c OTSU MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CILOSTAZOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN; SILDENAFIL;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BASILAR ARTERY; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; EXTRACELLULAR CALCIUM; FEMORAL ARTERY; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOLOGICAL BLOCKING; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

ANIMALS; CALCIUM; CELL PROLIFERATION; CEREBRAL ARTERIES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES; TETRAZOLES; VASODILATOR AGENTS;

ANIMALIA;

EID: 84866015282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044476     Document Type: Article

References (34)

1. Al-Qudah ZA, Hassan AE, Qureshi AI, (2011) Cilostazol in patients with ischemic stroke. Expert Opin Pharmacother 12: 1305-1315.
2. Sallustio F, Rotondo F, Di Legge S, Stanzione P, (2010) Cilostazol in the management of atherosclerosis. Curr Vasc Pharmacol 8: 363-372.
3. Nakamura K, Ikomi F, Ohhashi T, (2006) Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles. J Vasc Res 43: 86-94.
4. Shiraishi Y, Kanmura Y, Itoh T, (1998) Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit. Br J Pharmacol 123: 869-878.
5. Chen WJ, Chen YH, Lin KH, Ting CH, Yeh YH, (2011) Cilostazol Promotes Vascular Smooth Muscles Cell Differentiation Through the cAMP Response Element-Binding Protein-Dependent Pathway. Arterioscler Thromb Vasc Biol 31: 2106-2113.
6. Takahashi S, Oida K, Fujiwara R, Maeda H, Hayashi S, et al. (1992) Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 20: 900-906.
7. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, et al. (1990) Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 336: 633.
8. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, et al. (1992) The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77: 96-100.
9. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, et al. (1992) Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23: 1014-1016.
10. Alabadi JA, Salom JB, Torregrosa G, Miranda FJ, Jover T, et al. (1993) Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 33: 707-714; discussion 714-705.
11. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H, (1992) Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76: 99-105.
12. Kawanabe Y, Nauli SM, (2005) Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell Signal 17: 911-916.
13. Kawanabe Y, Nauli SM, (2011) Endothelin. Cell Mol Life Sci 68: 195-203.
14. AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, et al. (2009) Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ Res 104: 860-869.
15. Nauli SM, Kawanabe Y, Kaminski JJ, Pearce WJ, Ingber DE, et al. (2008) Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 117: 1161-1171.
16. Abdul-Majeed S, Moloney BC, Nauli SM, (2012) Mechanisms regulating cilia growth and cilia function in endothelial cells. Cell Mol Life Sci 69: 165-173.
17. Abdul-Majeed S, Nauli SM, (2011) Dopamine receptor type 5 in the primary cilia has dual chemo- and mechano-sensory roles. Hypertension 58: 325-331.
18. AbouAlaiwi WA, Ratnam S, Booth RL, Shah JV, Nauli SM, (2011) Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum Mol Genet 20: 354-367.
19. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, et al. (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129-137.
20. Kawanabe Y, Hashimoto N, Masaki T, (2002) Ca(2+) channels involved in endothelin-induced mitogenic response in carotid artery vascular smooth muscle cells. Am J Physiol Cell Physiol 282: C330-337.
21. Kawanabe Y, Masaki T, Hashimoto N, (2006) Involvement of phospholipase C in endothelin 1-induced stimulation of Ca++ channels and basilar artery contraction in rabbits. J Neurosurg 105: 288-293.
22. Sanganalmath SK, Barta J, Takeda N, Kumamoto H, Dhalla NS, (2008) Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction. Can J Physiol Pharmacol 86: 180-189.
23. Hefke T, Zittermann A, Fuchs U, Schulte-Eistrup S, Gummert JF, et al. (2011) Bosentan Effects on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hypertension Awaiting Cardiac Transplantation*. Thorac Cardiovasc Surg 60: 26-34.
24. Witteveen PO, van der Mijn KJ, Los M, Kronemeijer RH, Groenewegen G, et al. (2010) Phase 1/2 study of atrasentan combined with pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer. Neoplasia 12: 941-945.
25. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, et al. (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10: 618-625.
26. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, et al. (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249-252.
27. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, et al. (2009) Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. Faseb J 23: 2425-2437.
28. Abdul-Majeed S, Moloney BC, Nauli SM, (2011) Mechanisms regulating cilia growth and cilia function in endothelial cells. Cell Mol Life Sci.
29. Nauli SM, White CR, Hull AD, Pearce WJ, (2003) Maturation alters cyclic nucleotide and relaxation responses to nitric oxide donors in ovine cerebral arteries. Biol Neonate 83: 123-135.
30. Lucchi S, Calebiro D, de Filippis T, Grassi ES, Borghi MO, et al. (2011) 8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms. PLoS One 6: e20785.
31. Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, et al. (1988) Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 36: 313-320.
32. Nauli SM, Ally A, Zhang L, Gerthoffer WT, Pearce WJ, (2000) Maturation attenuates the effects of cGMP on contraction, [Ca2+]i and Ca2+ sensitivity in ovine basilar arteries. Gen Pharmacol 35: 107-118.
33. Nauli SM, Williams JM, Akopov SE, Zhang L, Pearce WJ, (2001) Developmental changes in ryanodine- and IP(3)-sensitive Ca(2+) pools in ovine basilar artery. Am J Physiol Cell Physiol 281: C1785-1796.
34. Nauli SM, Zhang L, Pearce WJ, (2001) Maturation depresses cGMP-mediated decreases in [Ca2+]i and Ca2+ sensitivity in ovine cranial arteries. Am J Physiol Heart Circ Physiol 280: H1019-1028.